Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer - PubMed (original) (raw)
Expression and function of beta 1 and alpha v beta 3 integrins in ovarian cancer
S A Cannistra et al. Gynecol Oncol. 1995 Aug.
Abstract
Ovarian cancer cells disseminate by implanting onto the peritoneal mesothelial cell surface of the abdominal cavity. A common feature of these peritoneal implants is the presence of tumor cell invasion into the submesothelial extracellular matrix (ECM). In view of the important role of integrins in ECM recognition and cell migration, we were interested in defining the pattern of integrin expression and function in ovarian cancer cell lines and primary tissue samples. The beta 1 integrin chain was expressed by CAOV-3, SKOV-3, OVCAR-3, and SW626 ovarian cancer cell lines, associated with expression of alpha 1, -2, -3, -5, and -6 chains. The alpha 4 chain was also expressed by two of the four lines. In addition to beta 1 integrins, the alpha v beta 3 integrin was also expressed, although there was no expression of beta 2, -4, and -7 chains. Immunoprecipitation of surface-labeled CAOV-3 cells with an anti-beta 1 antibody revealed a band at approximately 110-130 kDa consistent with the known molecular mass of the beta 1 chain, as well as several associated bands consistent with noncovalently linked integrin alpha chains. A similar pattern of beta 1 and alpha v beta 3 integrin expression was observed for primary ovarian cancer tissue samples. Ovarian cancer cell lines exhibited significant binding to collagen type I and laminin which was primarily mediated by beta 1 integrins. In contrast, ovarian cancer cell binding to fibronectin was mediated by both alpha 5 beta 1 and alpha v beta 3 integrins. Even though mesothelial cells were observed to express fibronectin mRNA and protein, binding of ovarian cancer cells to peritoneal mesothelium was not blocked by neutralizing antibodies to beta 1 or alpha v beta 3 integrins. These data suggest that functional integrins are commonly expressed by ovarian cancer cells, although they do not appear to mediate ovarian cancer cell implantation onto peritoneal mesothelium. The role that integrins play in the invasion of ovarian cancer cells into the submesothelial ECM deserves further investigation.
Similar articles
- Beta1-integrins partly mediate binding of ovarian cancer cells to peritoneal mesothelium in vitro.
Strobel T, Cannistra SA. Strobel T, et al. Gynecol Oncol. 1999 Jun;73(3):362-7. doi: 10.1006/gyno.1999.5388. Gynecol Oncol. 1999. PMID: 10366461 - Binding of ovarian cancer cells to peritoneal mesothelium in vitro is partly mediated by CD44H.
Cannistra SA, Kansas GS, Niloff J, DeFranzo B, Kim Y, Ottensmeier C. Cannistra SA, et al. Cancer Res. 1993 Aug 15;53(16):3830-8. Cancer Res. 1993. PMID: 8339295 - Integrin signaling and matrix assembly.
Ruoslahti E. Ruoslahti E. Tumour Biol. 1996;17(2):117-24. doi: 10.1159/000217975. Tumour Biol. 1996. PMID: 8658014 Review. - Role of RGD-binding Integrins in ovarian cancer progression, metastasis and response to therapy.
Ranga V, Dakal TC, Maurya PK, Johnson MS, Sharma NK, Kumar A. Ranga V, et al. Integr Biol (Camb). 2025 Jan 8;17:zyaf003. doi: 10.1093/intbio/zyaf003. Integr Biol (Camb). 2025. PMID: 39916547 Review.
Cited by
- Retargeting FX-binding-ablated HAdV-5 to vascular cells by inclusion of the RGD-4C peptide in hexon hypervariable region 7 and the HI loop.
Robertson S, Parker AL, Clarke C, Duffy MR, Alba R, Nicklin SA, Baker AH. Robertson S, et al. J Gen Virol. 2016 Aug;97(8):1911-1916. doi: 10.1099/jgv.0.000505. Epub 2016 May 16. J Gen Virol. 2016. PMID: 27189759 Free PMC article. - RGD-Conjugated Resveratrol HSA Nanoparticles as a Novel Delivery System in Ovarian Cancer Therapy.
Long Q, Zhu W, Guo L, Pu L. Long Q, et al. Drug Des Devel Ther. 2020 Dec 30;14:5747-5756. doi: 10.2147/DDDT.S248950. eCollection 2020. Drug Des Devel Ther. 2020. PMID: 33408463 Free PMC article. - Oncolytic virotherapy for ovarian cancer.
Li S, Tong J, Rahman MM, Shepherd TG, McFadden G. Li S, et al. Oncolytic Virother. 2012 Aug;1:1-21. doi: 10.2147/ov.s31626. Oncolytic Virother. 2012. PMID: 25977900 Free PMC article. - Absence of host-secreted protein acidic and rich in cysteine (SPARC) augments peritoneal ovarian carcinomatosis.
Said N, Motamed K. Said N, et al. Am J Pathol. 2005 Dec;167(6):1739-52. doi: 10.1016/S0002-9440(10)61255-2. Am J Pathol. 2005. PMID: 16314484 Free PMC article. - Cyclic AMP induces integrin-mediated cell adhesion through Epac and Rap1 upon stimulation of the beta 2-adrenergic receptor.
Rangarajan S, Enserink JM, Kuiperij HB, de Rooij J, Price LS, Schwede F, Bos JL. Rangarajan S, et al. J Cell Biol. 2003 Feb 17;160(4):487-93. doi: 10.1083/jcb.200209105. Epub 2003 Feb 10. J Cell Biol. 2003. PMID: 12578910 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical